Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Carbaglu

InhA, Func 1188-38-1
Catalog No. ABIN3220322
  • Application
    Inhibition Assay (InhA), Functional Studies (Func)
    Purpose
    Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death. Carglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010.
    Characteristics
    Tradename: Zemuron
    Source of Compound: synthetic
    Target: Amino Acids and Derivatives
    Receptor: Carbamoyl-phosphate synthase
    Purification
    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
    Purity
    98 %
    Formula
    C6H10N2O5
    Solubility
    10 mM in H2O
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Solid
    Storage
    -20 °C
    Storage Comment
    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
    Expiry Date
    24 months
  • Background
    Amino Acids & Building Blocks
    Molecular Weight
    190.15 g/mol
    CAS-No
    1188-38-1
You are here:
Support